ChemWerth

Approved

Woodbridge, United StatesFounded 1982chemwerth.com

Established in 1982 by Peter Werth, ChemWerth is a family-owned, global leader in the generic API sector, offering end-to-end services from product development to commercial supply. The company leverages exclusive partnerships with over 30 manufacturing facilities across the U.S., Europe, India, and China, and boasts a track record of over 550 worldwide regulatory approvals. Its core value proposition is enabling customers to reach the market faster through integrated technical, analytical, and regulatory support, with a focus on complex molecules, oncologicals, and antibiotics.

Founded

1982

Focus

Small MoleculesDrug Delivery

AI Company Overview

Technology Platform

ChemWerth's platform is an integrated service network for generic API development and supply, featuring an FDA-approved lab, a global cGMP manufacturing partnership network, and a regulatory team with over 550 worldwide approvals.

Opportunities

Growth opportunities include expanding its portfolio of complex and difficult-to-manufacture generic APIs (e.g., polypeptides, complex molecules), deepening penetration in emerging pharmaceutical markets, and leveraging its over 550 regulatory approvals to accelerate customer ANDA filings.

The growing veterinary pharmaceuticals sector also presents a significant adjacent market.

Risk Factors

Key risks include supply chain concentration and disruption from reliance on third-party manufacturers, particularly in China and India; intense pricing pressure in the generic API market; and the ever-present regulatory risk of compliance failures at partner facilities, which could trigger FDA actions and damage reputation.

Competitive Landscape

ChemWerth competes with large integrated API manufacturers (e.g., Dr. Reddy's, Aurobindo, Huahai) and specialized suppliers. Its main differentiation is its full-service, U.S.-based partnership model with deep regulatory expertise and a quality-audited global network, appealing to customers seeking cost-effective supply with robust regulatory support and supply chain security.